Denosumab Biosimilar Launch in Europe Could Be A Game Changer For Sandoz Group (SWX:SDZ) [Yahoo! Finance]
Evotec SE (EVO)
NASDAQ:AMEX Investor Relations:
eatonvance.com
Company Research
Source: Yahoo! Finance
Xgeva® and Prolia® indications, targeting cancer-related bone disease and osteoporosis. This move expands Sandoz's presence in a roughly US$6.60 billion reference-medicine market and underscores its long-term push into higher-value oncology and immunology biosimilars. We'll now examine how bringing Wyost and Jubbonti to Europe, alongside broader biosimilar expansion, affects Sandoz's investment narrative. Trump's oil boom is here - pipelines are primed to profit. Discover the 22 US stocks riding the wave To own Sandoz, you need to believe its growing biosimilar portfolio can offset pricing pressure in generics and support earnings growth. The Wyost and Jubbonti rollout in Europe reinforces this core biosimilar thesis, but does not change that the most important near term catalyst is execution on recent high profile launches, while the biggest risk remains intensifying price and margin pressure across both biosimilars and generics. The Just Evotec Biologics EU SAS acquisition
Show less
Read more
Impact Snapshot
Event Time:
EVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EVO alerts
High impacting Evotec SE news events
Weekly update
A roundup of the hottest topics
EVO
News
- FairJourney Biologics Appoints Dr. Werner Lanthaler as Chief Executive Officer [Yahoo! Finance]Yahoo! Finance
- LIRG(TM) Appoints Kurt Dinkelacker as Chief Financial Officer [Yahoo! Finance]Yahoo! Finance
- Financière de Tubize strengthens its expertise in the biopharma field by appointing 2 new directors [Yahoo! Finance]Yahoo! Finance